相关实验视频
Updated: Feb 10, 2026

07:58
Characterizing Mutational Load and Clonal Composition of Human Blood
Published on: July 11, 2019
7.9K
激活Ras-MAPK通路变体在人类中驱动海马克隆竞争.
bioRxiv : the preprint server for biology
|February 9, 2026
概括
拉斯-MAPK通路基因的体质变异在期叶 (MTLE) 中很常见,这是一个频繁的焦点. 这些在海马体中获得的遗传变化会影响风险和手术结果.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 的研究研究.
背景情况:
- 半径 (中间) 叶 (MTLE) 是最常见的焦点.
- 耐药性MTLE的治疗方法是前叶切除,通常会显示出海马硬化症 (HS).
- 虽然生殖系遗传学起到较小的作用,但Ras-MAPK通路基因的体变异被怀疑是MTLE的贡献者.
研究的目的:
- 研究MTLE体质Ras-MAPK变异的流行率,临床相关性和生物机制.
- 为了确定体质变异是否与对照人群相比在MTLE手术样本中得到丰富.
- 探索体质变异负担与MTLE手术结果之间的关联.
主要方法:
- 来自462个MTLE手术切除和对照的海马体DNA的有针对性的双重测序.
- 分析Ras-MAPK通路基因的体变异,包括新型基因.
- 单核RNA测序和在细胞模型中对已识别的变体的功能验证.
主要成果:
- 超过40%的MTLE标本显示已知和新基因中的Ras-MAPK变体被激活,与对照对比有显著的丰富.
- 八个Ras-MAPK基因在MTLE中表现出积极的克隆选择.
- 增加的体质变体负担与更糟糕的外科手术结果相关,并且与较早的发作发作和HS病理学有关.
结论:
- 人体Ras-MAPK变异在MTLE中很普遍,并且可能在发育早期出现.
- 这些变体富含特定的海马细胞类型,并影响基因表达,可能导致过度兴奋.
- 获得的风险因素和体质Ras-MAPK变异可能通过克隆竞争相互作用,增加风险.
相关概念视频
T Cell Activation and Clonal Selection
16.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.2K
Competition
24.9K
When organisms require the same limited resources within an environment, they may have to compete for them. Competition is a net-negative interaction. Even if two competing individuals or populations do not interact directly, the overall fitness of both competitors is lowered as a result of not having full access to the limited resource.
24.9K
The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
Histone Variants at the Centromere
5.1K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
MAPK Signaling Cascades
8.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.5K
Small GTPases - Ras and Rho
5.5K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.5K

